Evading the host response: Staphylococcus “hiding” in cortical bone canalicular system causes increased bacterial burden

Abstract

Extremity reconstruction surgery is increasingly performed rather than amputation for patients with large-segment pathologic bone loss. Debate persists as to the optimal void filler for this “limb salvage” surgery, whether metal or allograft bone. Clinicians focus on optimizing important functional gains for patients, and the risk of devastating implant infection has been thought to be similar regardless of implant material. Recent insights into infection pathophysiology are challenging this equipoise, however, with both basic science data suggesting a novel mechanism of infection of Staphylococcus aureus (the most common infecting agent) into the host lacunar–canaliculi network, and also clinical data revealing a higher rate of infection of allograft over metal. The current translational study was therefore developed to bridge the gap between these insights in a longitudinal murine model of infection of allograft bone and metal. Real-time Staphylococci infection characteristics were quantified in cortical bone vs metal, and both microarchitecture of host implant and presence of host immune response were assessed. An orders-of-magnitude higher bacterial burden was established in cortical allograft bone over both metal and cancellous bone. The establishment of immune-evading microabscesses was confirmed in both cortical allograft haversian canal and the submicron canaliculi network in an additional model of mouse femur bone infection. These study results reveal a mechanism by which Staphylococci evasion of host immunity is possible, contributing to elevated risks of infection in cortical bone. The presence of this local infection reservoir imparts massive clinical implications that may alter the current paradigm of osteomyelitis and bulk allograft infection treatment.

References

[1] Eckardt J, Matthews J 2nd, Eilber F. Endoprosthetic reconstruction after bone tumor resections of the proximal tibia. Ortho. Clin. North Am., 1991, 22:149-160

[2] Houdek MT et al. Long term outcomes of cemented endoprosthetic reconstruction for periarticular tumors of the distal femur. Knee, 2016, 23:167-172

[3] Donati D et al. The use of massive bone allografts for intercalary reconstruction and arthrodeses after tumor resection. A multicentric European study. Chir. Organi Mov., 1992, 78:81-94

[4] Gebhardt MC, Flugstad DI, Springfield DS, Mankin HJ. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin. Orthop. Relat. Res., 1991, 270:181-196

[5] Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW. Long-term results of allograft replacement in the management of bone tumors. Clin. Orthop. Relat. Res., 1996, 324:86-97

[6] Berrey BH Jr., Lord CF, Gebhardt MC, Mankin HJ. Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg. Am., 1990, 72:825-833

[7] Folleras, G. & Bjerkreim, I. Complications in a consecutive series of 48 allografts. in Complications of Limb Salvage: Prevention, Management and Outcome 81–86 (ISOLS, Montreal, 1991).

[8] Groundland JS et al. Surgical and functional outcomes after limb-preservation surgery for tumor in pediatric patients: a systematic review. JBJS Rev., 2016, 4:01874474-201602000-00002

[9] Mankin, H. Complications of allograft surgery. in Osteochondral Allografts. Biology, Banking, and Clinical Applications 259–274 (Little, Brown, Boston, 1983).

[10] Sorger, J. I. et al. Allograft fractures revisited. Clin. Orthop. Relat. Res. 66–74 (2001).

[11] Wilson RJ et al. Cost-utility of osteoarticular allograft versus endoprosthetic reconstruction for primary bone sarcoma of the knee: a markov analysis. J. Surg. Oncol., 2017, 115:257-265

[12] Henderson ER et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J. Bone Joint Surg. Am., 2011, 93:418-429

[13] Lord CF, Gebhardt MC, Tomford WW, Mankin HJ. Infection in bone allografts. Incidence, nature, and treatment. J. Bone Joint Surg. Am., 1988, 70:369-376

[14] Friedrich JB, Moran SL, Bishop AT, Wood CM, Shin AY. Free vascularized fibular graft salvage of complications of long-bone allograft after tumor reconstruction. J. Bone Joint Surg. Am., 2008, 90:93-100

[15] Myerson MS, Neufeld SK, Uribe J. Fresh-frozen structural allografts in the foot and ankle. J. Bone Joint Surg. Am., 2005, 87:113-120

[16] Muscolo DL, Ayerza MA, Aponte-Tinao L, Ranalletta M, Abalo E. Intercalary femur and tibia segmental allografts provide an acceptable alternative in reconstructing tumor resections. Clin. Orthop. Relat. Res., 2004, 426:97-102

[17] Witsø E, Persen L, Benum P, Bergh K. Cortical allograft as a vehicle for antibiotic delivery. Acta Orthop., 2005, 76:481-486

[18] Schwarz EM et al. 2018 international consensus meeting on musculoskeletal infection: research priorities from the general assembly questions. J. Orthop., 2019, 37:997-1006

[19] Aponte-Tinao LA, Ayerza MA, Muscolo DL, Farfalli GL. What are the risk factors and management options for infection after reconstruction with massive bone allografts? Clin. Orthop. Relat. Res., 2016, 474:669-673

[20] Peel T et al. Infective complications following tumour endoprosthesis surgery for bone and soft tissue tumours. Eur. J. Surg. Oncol., 2014, 40:1087-1094

[21] Tomford WW, Thongphasuk J, Mankin HJ, Ferraro MJ. Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J. Bone Joint Surg. Am., 1990, 72:1137-1143

[22] Beckmann NA et al. Treatment of severe bone defects during revision total knee arthroplasty with structural allografts and porous metal cones—a systematic review. J. Arthroplast., 2015, 30:249-253

[23] Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J. Bone Joint Surg. Am., 1995, 77:1154-1165

[24] Albergo JI et al. Proximal tibia reconstruction after bone tumor resection: are survivorship and outcomes of endoprosthetic replacement and osteoarticular allograft similar? Clin. Orthop. Relat. Res., 2017, 475:676-682

[25] de Mesy Bentley KL et al. Evidence of Staphylococcus aureus deformation, proliferation, and migration in canaliculi of live cortical bone in murine models of osteomyelitis. J. Bone Miner. Res., 2017, 32:985-990

[26] de Mesy Bentley KL, MacDonald A, Schwarz EM, Oh I. Chronic osteomyelitis with Staphylococcus aureus deformation in submicron canaliculi of osteocytes: a case report. JBJS Case Connect., 2018, 8

[27] Muthukrishnan G, Masters EA, Daiss JL, Schwarz EM. Mechanisms of immune evasion and bone tissue colonization that make Staphylococcus aureus the primary pathogen in osteomyelitis. Curr. Osteoporos. Rep., 2019, 17:395-404

[28] Masters EA et al. An in vitro platform for elucidating the molecular genetics of S. aureus invasion of the osteocyte lacuno-canalicular network during chronic osteomyelitis. Nanomedicine, 2019, 21:102039

[29] Masters EA et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”. Bone Res., 2019, 7:1-18

[30] Ghimire N et al. Direct microscopic observation of human neutrophil—Staphylococcus aureus interaction in vitro suggests a potential mechanism for initiation of biofilm infection on an implanted medical device. Infect. Immun., 2019, 87

[31] Bernthal NM et al. A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PloS ONE, 2010, 5

[32] Pribaz JR et al. Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study. J. Orthop. Res., 2012, 30:335-340

[33] Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J. Bone Joint Surg. Am., 2002, 84:716-720

[34] Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin. Orthop. Relat. Res., 1996, 329:300-309

[35] Alexeeff M, Mahomed N, Morsi E, Garbuz D, Gross A. Structural allograft in two-stage revisions for failed septic hip arthroplasty. J. Bone Joint Surg. Br., 1996, 78:213-216

[36] Ammon P, Stockley I. Allograft bone in two-stage revision of the hip for infection. Is it safe? J. Bone Joint. Surg. Br., 2004, 86:962-965

[37] Lee PTH, Clayton RA, Safir OA, Backstein DJ, Gross AE. Structural allograft as an option for treating infected hip arthroplasty with massive bone loss. Clin. Orthop. Relat. Res., 2011, 469:1016-1023

[38] Bauman RD, Lewallen DG, Hanssen AD. Limitations of structural allograft in revision total knee arthroplasty. Clin. Orthop. Relat. Res., 2009, 467:818-824

[39] Zimmerli, W. & Sendi, P. in Seminars in Immunopathology 295–306 (Springer, 2011).

[40] Antoci V et al. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials, 2008, 29:4684-4690

[41] Antoci V et al. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J. Orthop. Res., 2007, 25:858-866

[42] Dworsky EE et al. Novel in vivo mouse model of implant related spine infection. J. Orthop. Res., 2016, 35:193-199

[43] Goorin AM et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J. Clin. Oncol., 2003, 21:1574-1580

[44] Basaran M et al. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas. Oncology, 2007, 72:255-260

[45] Nair SP et al. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun., 1996, 64:2371-2380

[46] Lowy FD. Staphylococcus aureus infections. N. Engl. J. Med., 1998, 339:520-532

[47] Hamza T, Li B. Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection. BMC Microbiol., 2014, 14

[48] Reilly S, Hudson M, Kellam J, Ramp W. In vivo internalization of Staphylococcus aureus by embryonic chick osteoblasts. Bone, 2000, 26:63-70

[49] Nango N et al. Osteocyte-directed bone demineralization along canaliculi. Bone, 2016, 84:279-288

[50] You LD, Weinbaum S, Cowin SC, Schaffler MB. Ultrastructure of the osteocyte process and its pericellular matrix. Anat. Rec. A, 2004, 278:505-513

[51] Foster, T. in Medical Microbiology 4th edn (ed. Baron S.) (University of Texas Medical Branch at Galveston, 1996).

[52] Mariotto SFF et al. Porous stainless steel for biomedical applications. Mater. Res., 2011, 14:146-154

[53] Lee, S. et al. Potential bone replacement materials prepared by two methods. in MRS Online Proceedings Library Archive, Vol. 1418 Cambridge University Press, Cambridge, England (2012).

[54] Schwarz, E. M. et al. Adjuvant antibiotic-loaded bone cement: concerns with current use and research to make it work. J. Orthop. Res. (2020). https://doi.org/10.1002/jor.24616. Online ahead of print.

[55] Yang D et al. Novel insights into Staphylococcus aureus deep bone infections: the involvement of osteocytes. MBio, 2018, 9:e00415-e00418

[56] Mankin HJ, Hornicek FJ, Raskin KA. Infection in massive bone allografts. Clin. Orthop. Relat. Res., 2005, 432:210-216

[57] Ketonis C, Barr S, Adams CS, Hickok NJ, Parvizi J. Bacterial colonization of bone allografts: establishment and effects of antibiotics. Clin. Orthop. Relat. Res., 2010, 468:2113-2121

[58] Dastgheyb SS, Toorkey CB, Shapiro IM, Hickok NJ. Porphyrin-adsorbed allograft bone: a photoactive, antibiofilm surface. Clin. Orthop. Relat. Res., 2015, 473:2865-2873

[59] Brooks BD, Davidoff SN, Grainger DW, Brooks AE. Comparisons of release of several antibiotics from antimicrobial polymer-coated allograft bone void filler. Int J. Biomed. Mater. Res, 2013, 1:21-25

[60] Reikeras O, Sigurdsen UW, Shegarfi H. Impact of freezing on immunology and incorporation of bone allograft. J. Orthop. Res., 2010, 28:1215-1219

[61] Francis KP et al. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun., 2000, 68:3594-3600

[62] Kim M-H, Curry F-RE, Simon SI. Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am. J. Physiol. Cell Physiol., 2009, 296:C848-C856

[63] Kim M-H et al. Dynamics of neutrophil infiltration during cutaneous wound healing and infection using fluorescence imaging. J. Investig. Dermatol., 2008, 128:1812-1820

[64] DePaula C, Truncale K, Gertzman A, Sunwoo M, Dunn M. Effects of hydrogen peroxide cleaning procedures on bone graft osteoinductivity and mechanical properties. Cell Tissue Bank., 2005, 6:287-298

[65] Cool SK, Breyne K, Meyer E, De Smedt SC, Sanders NN. Comparison of in vivo optical systems for bioluminescence and fluorescence imaging. J. Fluoresc., 2013, 23:909-920

[66] Filoche SK, Coleman MJ, Angker L, Sissons CH. A fluorescence assay to determine the viable biomass of microcosm dental plaque biofilms. J. Microbiol. Methods, 2007, 69:489-496

Funding

Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)(5K08AR069112-01)

Musculoskeletal Transplant Foundation/Musculoskeletal Tumor Society